Ischemic Cardiomyopathy Clinical Trials

13 recruiting

Ischemic Cardiomyopathy Trials at a Glance

23 actively recruiting trials for ischemic cardiomyopathy are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Not Applicable with 10 trials, with the heaviest enrollment activity in Cleveland, Tomsk, and Beijing. Lead sponsors running ischemic cardiomyopathy studies include Samsung Medical Center, The Cleveland Clinic, and Tomsk National Research Medical Center of the Russian Academy of Sciences.

Browse ischemic cardiomyopathy trials by phase

Treatments under study

About Ischemic Cardiomyopathy Clinical Trials

Looking for clinical trials for Ischemic Cardiomyopathy? There are currently 13 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Ischemic Cardiomyopathy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Ischemic Cardiomyopathy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 23 trials

Recruiting
Not Applicable

RestoratIon of Myocardial Function by PeRcutaneous cOronary interVEntion in Patients With Ischemic CardioMyoPathy

Ischemic Cardiomyopathy
Seoul National University Hospital158 enrolled1 locationNCT06930092
Recruiting
Phase 2

Venous Ethanol for Ventricular Tachycardia

Ventricular TachycardiaIschemic Cardiomyopathy
The Methodist Hospital Research Institute156 enrolled1 locationNCT05511246
Recruiting
Not Applicable

Performance of the Cardiac Microcurrent (C-MIC) System With a Less Invasively Placed Left Ventricular Lead

Non-ischemic CardiomyopathyLeft Ventricular (LV) Systolic DysfunctionIdiopathic Cardiomyopathy
Berlin Heals GmbH22 enrolled4 locationsNCT06920030
Recruiting
Phase 2

PET Myocardial Fatty-acid Metabolic Imaging With XTR003 Injection and 18F-FDG to Assess Myocardial Viability in Ischemic Cardiomyopathy

Heart FailureIschemic Cardiomyopathy
Sinotau Pharmaceutical Group40 enrolled3 locationsNCT07443696
Recruiting

Cardiac Magnetic Resonance for Risk Stratification in Non-dilated Left Ventricular Cardiomyopathy

Non-ischemic Cardiomyopathy
Chinese Academy of Medical Sciences, Fuwai Hospital1,000 enrolled1 locationNCT07351838
Recruiting

Left Ventricular Structural Predictors of Sudden Cardiac Death

Ischemic CardiomyopathyNonischemic Cardiomyopathy
Johns Hopkins University400 enrolled2 locationsNCT01076660
Recruiting
Phase 1Phase 2

A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure

Chronic Heart FailureCoronary Artery Bypass Grafting (CABG)Chronic Ischemic Cardiomyopathy
Tasly Pharmaceutical Group Co., Ltd51 enrolled4 locationsNCT07265349
Recruiting
Not Applicable

Cardiac RadiothErapy For hEart faiLure

Heart FailureNon-ischemic CardiomyopathyIschemic Cardiomyopathy
Universitaire Ziekenhuizen KU Leuven40 enrolled1 locationNCT06661876
Recruiting

Phenotypic Classification of FMR With CMR

Functional Mitral RegurgitationIschemic CardiomyopathyNonischemic Congestive Cardiomyopathy
The Cleveland Clinic360 enrolled1 locationNCT05965258
Recruiting
Not Applicable

Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy

Ventricular TachycardiaIschemic Cardiomyopathy
Rush University Medical Center100 enrolled5 locationsNCT06138873
Recruiting
Not Applicable

Conventional Biventricular Versus Left Bundle Branch Pacing on Outcomes in Heart Failure Patients

Heart FailureNon-ischemic Dilated CardiomyopathyLeft Bundle-Branch Block+4 more
Tomsk National Research Medical Center of the Russian Academy of Sciences60 enrolled1 locationNCT05769036
Recruiting

Non-ischemic Cardiomyopathy Registry, Biobank and Imaging Data Repository

Non-ischemic Cardiomyopathy
Montreal Heart Institute2,000 enrolled1 locationNCT07110818
Recruiting
Not Applicable

Endo-epicardial vs Endocardial-only Catheter Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy (EPIC-VT)

Ischemic CardiomyopathyCatheter Ablation of Ventricular Tachycardia
Rennes University Hospital150 enrolled12 locationsNCT05888662
Recruiting

Development of CIRC Technologies

Heart FailureCardiovascular DiseasesAtrial Fibrillation+7 more
The Cleveland Clinic1,000 enrolled1 locationNCT05654272
Recruiting
Not Applicable

Revascularization Versus Medical Treatment in Patients With Ischemic Left Ventricular Dysfunction

Heart Failure With Reduced Ejection FractionIschemic Cardiomyopathy
Samsung Medical Center900 enrolled1 locationNCT05828719
Recruiting
Not Applicable

LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB

Heart FailureNon-ischemic CardiomyopathyLeft Bundle-Branch Block
The First Affiliated Hospital with Nanjing Medical University50 enrolled6 locationsNCT05572957
Recruiting

Cardiovascular Multimodality Imaging Study

CardiomyopathiesSarcoidosisHypertrophic Cardiomyopathy+4 more
Montefiore Medical Center5,000 enrolled1 locationNCT06610019
Recruiting
Not Applicable

Left Bundle Branch Pacing on Outcomes and Ventricular Remodeling in Biventricular CRT Nonresponders

Heart FailureNon-ischemic Dilated CardiomyopathyLeft Bundle-Branch Block+3 more
Tomsk National Research Medical Center of the Russian Academy of Sciences30 enrolled1 locationNCT05760924
Recruiting

Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.

Hypertrophic Cardiomyopathy (HCM)Non-ischemic CardiomyopathyRestrictive Cardiomyopathy+2 more
Scientific Institute San Raffaele15,000 enrolled1 locationNCT06607471
Recruiting
Not Applicable

Atrial Appendage Micrograft Transplants to Assist Heart Repair After Cardiac Surgery

Coronary Artery DiseaseHeart Failure NYHA Class IIIHeart Failure NYHA Class IV+4 more
Hospital District of Helsinki and Uusimaa50 enrolled1 locationNCT05632432